In this episode, Michelle delves into Google's strategic ambitions in the AI sector, providing insight into their long-term vision. She then explores Microsoft's unveiling of BitNet b1.58 2B4T, discussing its potential impact on the industry. The conversation shifts to Isomorphic Labs and their pioneering AI-first approach to drug discovery, which could revolutionize the pharmaceutical landscape. Additionally, Michelle covers OpenAI's introduction of a new safety system designed to enhance the security of AI models. The episode wraps up with concluding thoughts on these developments and their implications for the future of artificial intelligence.
Fler avsnitt av The AI News Daily Brief
Visa alla avsnitt av The AI News Daily BriefThe AI News Daily Brief med PodcastAI finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.
